10 20 30 40 50 60 70 80 1NHW - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER OXIDOREDUCTASE 19-DEC-02 1NHW
TITLE CRYSTAL STRUCTURE ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL- TITLE 2 ACYL-CARRIER-PROTEIN REDUCTASE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-ACYL CARRIER REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ENOYL-ACP-REDUCTASE; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ENOYL-ACYL CARRIER REDUCTASE; COMPND 9 CHAIN: C, D; COMPND 10 SYNONYM: ENOYL-ACP-REDUCTASE; COMPND 11 EC: 1.3.1.9; COMPND 12 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 4 ORGANISM_TAXID: 5833; SOURCE 5 EXPRESSION_SYSTEM: BACTERIA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: EUBACTERIA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 2; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: BL21(DE3) CODONPLUS-RIL; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PLASMID; SOURCE 10 OTHER_DETAILS: PET28A; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 13 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 14 ORGANISM_TAXID: 5833; SOURCE 15 EXPRESSION_SYSTEM: BACTERIA; SOURCE 16 EXPRESSION_SYSTEM_COMMON: EUBACTERIA; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 2; SOURCE 18 EXPRESSION_SYSTEM_VARIANT: BL21(DE3) CODONPLUS-RIL; SOURCE 19 EXPRESSION_SYSTEM_PLASMID: PLASMID; SOURCE 20 OTHER_DETAILS: PET28A
KEYWDS ROSSMANN FOLD, SHORT CHAIN DEHYDROGENASE REDUCTASE, NADH, KEYWDS 2 OXIDOREDUCTASE
EXPDTA X-RAY DIFFRACTION
AUTHOR R.PEROZZO,M.KUO,A.S.SIDHU,J.T.VALIYAVEETTIL,R.BITTMAN, AUTHOR 2 W.R.JACOBS JR.,D.A.FIDOCK,J.C.SACCHETTINI
REVDAT 2 24-FEB-09 1NHW 1 VERSN REVDAT 1 25-FEB-03 1NHW 0
JRNL AUTH R.PEROZZO,M.KUO,A.S.SIDHU,J.T.VALIYAVEETTIL, JRNL AUTH 2 R.BITTMAN,W.R.JACOBS JR.,D.A.FIDOCK,J.C.SACCHETTINI JRNL TITL STRUCTURAL ELUCIDATION OF THE SPECIFICITY OF THE JRNL TITL 2 ANTIBACTERIAL AGENT TRICLOSAN FOR MALARIAL ENOYL JRNL TITL 3 ACYL CARRIER PROTEIN REDUCTASE YEAR JRNL REF J.BIOL.CHEM. V. 277 13106 2002 JRNL REFN ISSN 0021-9258 JRNL PMID 11792710 JRNL DOI 10.1074/JBC.M112000200
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 28833 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2883 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4578 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 120 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1NHW COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-JAN-03. REMARK 100 THE RCSB ID CODE IS RCSB017883.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-FEB-01 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MACSCIENCE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28833 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.35 M (NH4)2SO4, 100 MM SODIUM REMARK 280 ACETATE PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 282K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.93100 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 66.68250 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 66.68250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.89650 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 66.68250 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 66.68250 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 20.96550 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 66.68250 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 66.68250 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.89650 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 66.68250 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 66.68250 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 20.96550 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 41.93100 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 13290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24800 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -79.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 37130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 39070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -237.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 133.36500 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 133.36500 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 41.93100
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 154 -76.24 17.39 REMARK 500 LYS A 155 45.72 -57.91 REMARK 500 ASP A 156 3.62 59.31 REMARK 500 MET A 189 20.82 -66.49 REMARK 500 ASN A 210 19.02 -141.64 REMARK 500 ASP B 107 -167.06 -168.22 REMARK 500 ILE B 153 43.38 -99.12 REMARK 500 ASP B 154 -72.16 56.06 REMARK 500 LYS B 155 47.83 -62.18 REMARK 500 ASP B 156 -13.50 61.49 REMARK 500 ILE B 323 78.08 -63.45 REMARK 500 THR C 367 133.88 60.57 REMARK 500 ASP C 414 29.19 -145.77 REMARK 500 ASN C 415 16.11 58.75 REMARK 500 THR D 367 150.42 57.50 REMARK 500 ASP D 414 37.21 -147.94 REMARK 500 ASP D 424 -89.30 -72.08 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 450 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 550 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TCC A 600 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TCC B 700
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NHD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL- REMARK 900 ACYL-CARRIER-PROTEIN REDUCTASE WITH NADH REMARK 900 RELATED ID: 1NHG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL- REMARK 900 ACYL-CARRIER-PROTEIN REDUCTASE WITH TRICLOSAN
DBREF 1NHW A 97 325 UNP Q9BH77 Q9BH77_PLAFA 97 325 DBREF 1NHW B 97 325 UNP Q9BH77 Q9BH77_PLAFA 97 325 DBREF 1NHW C 366 425 UNP Q9BH77 Q9BH77_PLAFA 366 425 DBREF 1NHW D 366 425 UNP Q9BH77 Q9BH77_PLAFA 366 425
SEQRES 1 A 229 GLU ASP ILE CYS PHE ILE ALA GLY ILE GLY ASP THR ASN SEQRES 2 A 229 GLY TYR GLY TRP GLY ILE ALA LYS GLU LEU SER LYS ARG SEQRES 3 A 229 ASN VAL LYS ILE ILE PHE GLY ILE TRP PRO PRO VAL TYR SEQRES 4 A 229 ASN ILE PHE MET LYS ASN TYR LYS ASN GLY LYS PHE ASP SEQRES 5 A 229 ASN ASP MET ILE ILE ASP LYS ASP LYS LYS MET ASN ILE SEQRES 6 A 229 LEU ASP MET LEU PRO PHE ASP ALA SER PHE ASP THR ALA SEQRES 7 A 229 ASN ASP ILE ASP GLU GLU THR LYS ASN ASN LYS ARG TYR SEQRES 8 A 229 ASN MET LEU GLN ASN TYR THR ILE GLU ASP VAL ALA ASN SEQRES 9 A 229 LEU ILE HIS GLN LYS TYR GLY LYS ILE ASN MET LEU VAL SEQRES 10 A 229 HIS SER LEU ALA ASN ALA LYS GLU VAL GLN LYS ASP LEU SEQRES 11 A 229 LEU ASN THR SER ARG LYS GLY TYR LEU ASP ALA LEU SER SEQRES 12 A 229 LYS SER SER TYR SER LEU ILE SER LEU CYS LYS TYR PHE SEQRES 13 A 229 VAL ASN ILE MET LYS PRO GLN SER SER ILE ILE SER LEU SEQRES 14 A 229 THR TYR HIS ALA SER GLN LYS VAL VAL PRO GLY TYR GLY SEQRES 15 A 229 GLY GLY MET SER SER ALA LYS ALA ALA LEU GLU SER ASP SEQRES 16 A 229 THR ARG VAL LEU ALA TYR HIS LEU GLY ARG ASN TYR ASN SEQRES 17 A 229 ILE ARG ILE ASN THR ILE SER ALA GLY PRO LEU LYS SER SEQRES 18 A 229 ARG ALA ALA THR ALA ILE ASN LYS SEQRES 1 B 229 GLU ASP ILE CYS PHE ILE ALA GLY ILE GLY ASP THR ASN SEQRES 2 B 229 GLY TYR GLY TRP GLY ILE ALA LYS GLU LEU SER LYS ARG SEQRES 3 B 229 ASN VAL LYS ILE ILE PHE GLY ILE TRP PRO PRO VAL TYR SEQRES 4 B 229 ASN ILE PHE MET LYS ASN TYR LYS ASN GLY LYS PHE ASP SEQRES 5 B 229 ASN ASP MET ILE ILE ASP LYS ASP LYS LYS MET ASN ILE SEQRES 6 B 229 LEU ASP MET LEU PRO PHE ASP ALA SER PHE ASP THR ALA SEQRES 7 B 229 ASN ASP ILE ASP GLU GLU THR LYS ASN ASN LYS ARG TYR SEQRES 8 B 229 ASN MET LEU GLN ASN TYR THR ILE GLU ASP VAL ALA ASN SEQRES 9 B 229 LEU ILE HIS GLN LYS TYR GLY LYS ILE ASN MET LEU VAL SEQRES 10 B 229 HIS SER LEU ALA ASN ALA LYS GLU VAL GLN LYS ASP LEU SEQRES 11 B 229 LEU ASN THR SER ARG LYS GLY TYR LEU ASP ALA LEU SER SEQRES 12 B 229 LYS SER SER TYR SER LEU ILE SER LEU CYS LYS TYR PHE SEQRES 13 B 229 VAL ASN ILE MET LYS PRO GLN SER SER ILE ILE SER LEU SEQRES 14 B 229 THR TYR HIS ALA SER GLN LYS VAL VAL PRO GLY TYR GLY SEQRES 15 B 229 GLY GLY MET SER SER ALA LYS ALA ALA LEU GLU SER ASP SEQRES 16 B 229 THR ARG VAL LEU ALA TYR HIS LEU GLY ARG ASN TYR ASN SEQRES 17 B 229 ILE ARG ILE ASN THR ILE SER ALA GLY PRO LEU LYS SER SEQRES 18 B 229 ARG ALA ALA THR ALA ILE ASN LYS SEQRES 1 C 60 TYR THR PHE ILE ASP TYR ALA ILE GLU TYR SER GLU LYS SEQRES 2 C 60 TYR ALA PRO LEU ARG GLN LYS LEU LEU SER THR ASP ILE SEQRES 3 C 60 GLY SER VAL ALA SER PHE LEU LEU SER ARG GLU SER ARG SEQRES 4 C 60 ALA ILE THR GLY GLN THR ILE TYR VAL ASP ASN GLY LEU SEQRES 5 C 60 ASN ILE MET PHE LEU PRO ASP ASP SEQRES 1 D 60 TYR THR PHE ILE ASP TYR ALA ILE GLU TYR SER GLU LYS SEQRES 2 D 60 TYR ALA PRO LEU ARG GLN LYS LEU LEU SER THR ASP ILE SEQRES 3 D 60 GLY SER VAL ALA SER PHE LEU LEU SER ARG GLU SER ARG SEQRES 4 D 60 ALA ILE THR GLY GLN THR ILE TYR VAL ASP ASN GLY LEU SEQRES 5 D 60 ASN ILE MET PHE LEU PRO ASP ASP
HET NAD A 450 44 HET NAD B 550 44 HET TCC A 600 16 HET TCC B 700 16
HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM TCC 2-(2,4-DICHLORO-PHENYLAMINO)-PHENOL
FORMUL 5 NAD 2(C21 H27 N7 O14 P2) FORMUL 7 TCC 2(C12 H9 CL2 N O)
HELIX 1 1 GLY A 110 ARG A 122 1 13 HELIX 2 2 TRP A 131 ASN A 144 1 14 HELIX 3 3 PHE A 147 ASP A 150 5 4 HELIX 4 4 THR A 173 ILE A 177 5 5 HELIX 5 5 ASP A 178 ASN A 183 1 6 HELIX 6 6 ASN A 184 MET A 189 1 6 HELIX 7 7 THR A 194 GLY A 207 1 14 HELIX 8 8 ASP A 225 THR A 229 5 5 HELIX 9 9 SER A 230 SER A 242 1 13 HELIX 10 10 SER A 242 VAL A 253 1 12 HELIX 11 11 TYR A 267 GLN A 271 5 5 HELIX 12 12 GLY A 280 ASN A 304 1 25 HELIX 13 13 SER A 317 ALA A 322 1 6 HELIX 14 14 GLY B 110 ARG B 122 1 13 HELIX 15 15 TRP B 131 PRO B 133 5 3 HELIX 16 16 VAL B 134 ASN B 144 1 11 HELIX 17 17 THR B 173 ILE B 177 5 5 HELIX 18 18 ASP B 178 ASN B 184 1 7 HELIX 19 19 ASN B 184 MET B 189 1 6 HELIX 20 20 THR B 194 GLY B 207 1 14 HELIX 21 21 ASP B 225 THR B 229 5 5 HELIX 22 22 SER B 230 SER B 242 1 13 HELIX 23 23 SER B 242 VAL B 253 1 12 HELIX 24 24 TYR B 267 GLN B 271 5 5 HELIX 25 25 GLY B 280 TYR B 303 1 24 HELIX 26 26 SER B 317 ILE B 323 1 7 HELIX 27 27 THR C 367 ALA C 380 1 14 HELIX 28 28 LEU C 387 SER C 400 1 14 HELIX 29 29 ARG C 401 ARG C 404 5 4 HELIX 30 30 GLY C 416 MET C 420 5 5 HELIX 31 31 TYR D 366 ALA D 380 1 15 HELIX 32 32 LEU D 387 SER D 400 1 14 HELIX 33 33 ARG D 401 ARG D 404 5 4 HELIX 34 34 GLY D 416 MET D 420 5 5
SHEET 1 A 7 ILE A 161 PRO A 166 0 SHEET 2 A 7 LYS A 125 ILE A 130 1 N PHE A 128 O LEU A 165 SHEET 3 A 7 ILE A 99 ILE A 105 1 N CYS A 100 O LYS A 125 SHEET 4 A 7 ILE A 209 HIS A 214 1 O VAL A 213 N ALA A 103 SHEET 5 A 7 MET A 256 THR A 266 1 O ILE A 263 N HIS A 214 SHEET 6 A 7 ARG A 306 ALA A 312 1 O ILE A 310 N SER A 264 SHEET 7 A 7 THR C 410 VAL C 413 1 O ILE C 411 N SER A 311 SHEET 1 B 2 ILE A 152 ILE A 153 0 SHEET 2 B 2 LYS A 157 LYS A 158 -1 O LYS A 157 N ILE A 153 SHEET 1 C 7 ILE B 161 PRO B 166 0 SHEET 2 C 7 LYS B 125 ILE B 130 1 N ILE B 130 O LEU B 165 SHEET 3 C 7 ILE B 99 ALA B 103 1 N CYS B 100 O LYS B 125 SHEET 4 C 7 ILE B 209 HIS B 214 1 O VAL B 213 N PHE B 101 SHEET 5 C 7 MET B 256 THR B 266 1 O ILE B 263 N HIS B 214 SHEET 6 C 7 ARG B 306 ALA B 312 1 O ILE B 310 N THR B 266 SHEET 7 C 7 THR D 410 VAL D 413 1 O ILE D 411 N SER B 311
SITE 1 AC1 22 ILE A 105 GLY A 106 GLY A 110 TYR A 111 SITE 2 AC1 22 TRP A 131 PHE A 167 ASP A 168 ALA A 169 SITE 3 AC1 22 SER A 215 LEU A 216 ALA A 217 ASN A 218 SITE 4 AC1 22 LEU A 265 THR A 266 LYS A 285 ALA A 312 SITE 5 AC1 22 GLY A 313 PRO A 314 LEU A 315 SER A 317 SITE 6 AC1 22 ALA A 319 TCC A 600 SITE 1 AC2 23 ILE B 105 GLY B 106 GLY B 110 TYR B 111 SITE 2 AC2 23 TRP B 131 PHE B 167 ASP B 168 ALA B 169 SITE 3 AC2 23 SER B 215 LEU B 216 ALA B 217 ASN B 218 SITE 4 AC2 23 LEU B 265 THR B 266 TYR B 267 LYS B 285 SITE 5 AC2 23 ALA B 312 GLY B 313 PRO B 314 LEU B 315 SITE 6 AC2 23 SER B 317 ALA B 319 TCC B 700 SITE 1 AC3 8 ALA A 217 ALA A 219 TYR A 277 ALA A 319 SITE 2 AC3 8 ALA A 320 ILE A 323 NAD A 450 ILE C 369 SITE 1 AC4 9 ALA B 217 ASN B 218 ALA B 219 VAL B 222 SITE 2 AC4 9 TYR B 277 ALA B 319 ALA B 320 ILE B 323 SITE 3 AC4 9 NAD B 550
CRYST1 133.365 133.365 83.862 90.00 90.00 90.00 P 43 21 2 16
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.007498 0.000000 0.000000 0.00000
SCALE2 0.000000 0.007498 0.000000 0.00000
SCALE3 0.000000 0.000000 0.011924 0.00000